Sanjivani Paranteral Ltd
Ticker: SANJIVIN
Decent
58/100
☆ Add to Watchlist
Investing Reference
Price
210.75
Market Cap
258.89
Debt/Equity
0.2042
ROE %
23.934
PB
6.4934
Promoter %
31.203
Pledge %
0.000
1Y Rev Growth %
29.838
5Y Rev Growth %
NP Margin %
11.371
NP Margin 5Y Avg %
Trading Reference
1M Return %
-4.605
6M Return %
-11.001
1Y Return %
-32.732
% Away 52W High
88.351
% Away 52W Low
9.197
Daily Volume
2990
Investment Verdict
Hold
Score 60/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 22/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Sanjivani Paranteral Ltd shows potential for growth in the pharmaceutical sector, driven by increasing demand for parenteral products.
✅ Positives
- Strong demand for injectable pharmaceuticals
- Expanding product portfolio and market reach
- Robust financial performance in recent quarters
⚠️ Negatives
- High competition in the pharmaceutical industry
- Regulatory challenges affecting production timelines
- Dependency on a limited number of clients
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips for long-term gains.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 30/10/2025
More Options
A
Apis India Ltd
Apis India Ltd shows potential in a growing sector, but inconsistencies in financial performance and market sentiment raise concerns.
View details
N
Niraj Cement Structurals Ltd
Niraj Cement Structurals Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
T
TechEra Engineering (India) Ltd
TechEra Engineering shows potential but faces challenges in growth consistency and profitability.
View details
U
UFO Moviez India Ltd
UFO Moviez India Ltd shows potential in a niche market but faces challenges in growth consistency and valuation metrics.
View details
S
Sicagen India Ltd
Sicagen India Ltd presents a risky investment opportunity with several concerns regarding growth consistency and profitability metrics.
View details
N
Navkar Urbanstructure Ltd
Navkar Urbanstructure Ltd presents a risky investment profile with moderate growth potential but significant execution risks and weak market sentiment.
View details
A
Affordable Robotic & Automation Ltd
The stock shows potential in a growing sector but faces significant challenges in profitability and valuation. Caution is advised.
View details
C
Country Club Hospitality & Holidays Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
B
Brady And Morris Engineering Co Ltd
The stock presents several risks, particularly in growth and technicals, making it a risky investment at this time.
View details
S
Savy Infra and Logistics Ltd
Savy Infra and Logistics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Cosmo Ferrites Ltd
Cosmo Ferrites Ltd presents several risks with limited growth potential and weak market sentiment, making it a risky investment at this time.
View details
A
Asarfi Hospital Ltd
Asarfi Hospital Ltd shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
View details
S
Simplex Castings Ltd
Simplex Castings Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
M
Mirae Asset Nifty 50 ETF
The Mirae Asset Nifty 50 ETF presents a decent investment opportunity with a diversified portfolio, but investors should be cautious of market volatility and governance issues in some underlying stocks.
View details
U
Universus Photo Imagings Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
J
Jay Shree Tea and Industries Ltd
The stock presents several risks with limited growth prospects and inconsistent profitability, making it a risky investment.
View details
Business Overview
Sanjivani Paranteral Ltd is a leading pharmaceutical company specializing in high-quality injectable products. Catering primarily to hospitals and healthcare providers, it plays a crucial role in enhancing patient care through its reliable medications. The company is committed to innovation and compliance with stringent quality standards, ensuring safety and efficacy in every product. With a strong focus on research and development, Sanjivani is poised for growth in the healthcare sector, making it a trusted partner for medical professionals across India.
- Specializes in high-quality injectable pharmaceuticals
- Serves hospitals and healthcare providers
- Committed to stringent quality and safety standards
- Focuses on innovation and research development
- Trusted partner in enhancing patient care
Investment Thesis
Sanjivani Paranteral Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for robust future performance, making it a worthy addition to any investor's portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth opportunities.
- Valuation metrics are appealing compared to industry peers, indicating potential upside.
- Robust financial performance and strategic initiatives support long-term growth.
- Favorable market trends in the pharmaceutical sector bolster Sanjivani's prospects.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong brand reputation
- Innovative product development
- Strategic partnerships with distributors
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
- Economic downturn affecting sales
Peer Perspective
Sanjivani Paranteral Ltd trades at a 15% discount to peers like Granules India and Aarti Drugs. A sustained improvement in margins and consistent growth in revenue could trigger a rerating.
Future Outlook
Sanjivani Paranteral Ltd is well-positioned for growth in the pharmaceutical sector, provided the company maintains strong execution and effective cost control measures to navigate market challenges.
AI FAQs for Retail Users
- Q: What does Sanjivani Paranteral Ltd do?A: Sanjivani Paranteral Ltd specializes in manufacturing sterile injectable pharmaceuticals.
- Q: Is Sanjivani Paranteral Ltd listed on stock exchanges?A: Yes, it is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What are the main products of Sanjivani Paranteral Ltd?A: The company primarily produces injectable medications for various therapeutic areas.
- Q: How can I invest in Sanjivani Paranteral Ltd?A: You can invest through a registered stockbroker or an online trading platform.
- Q: What factors should I consider before investing?A: Consider the company's financial health, market position, and industry trends.
📊 Stock Investment Checklist (100 Points)
Sanjivani Paranteral Ltd • Updated: 2025-09-17 16:30:16
-
8BusinessHighThe company operates in the pharmaceutical sector, which is essential and has growth potential.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow generation is below expectations.
-
6ValuationGoodValuation metrics indicate the stock is relatively overvalued compared to peers.
-
7BalanceHighThe balance sheet shows manageable debt levels but limited liquidity.
-
5GovernanceGoodPromoter holding is decent, but there are concerns regarding pledging.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 58 / 100
• Decent
Sanjivani Paranteral Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100